Safety of Sports for Patients With a Subcutaneous Implantable Cardioverter Defibrillator

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-01

Study Completion Date

2029-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A multicenter observational study designed specifically to collect data on the safety of sport activities in patients with implanted S-ICD systems.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety of Sports for Patients With Implantable Cardioverter-Defibrillators

NCT00637754

Heart Arrhythmias

COMPLETED

S-ICD® System Post Approval Study

NCT01736618

Primary Prevention of Sudden Cardiac Arrest Secondary Prevention of Sudden Cardiac Arrest

COMPLETED

Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation

NCT01117792

ACC/AHA/NASPE Class 1, IIa or IIb Indications

COMPLETED NA

Reduction of Myopotential Interference With Smart Pass in S-ICD Patients

NCT05766943

Subcutaneous ICD Myopotential Interference

RECRUITING NA

Initial Chronic Human Validation Study: Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) System

NCT00853645

Ventricular Tachyarrhythmias

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Observational multicenter study with prospective follow-up but accepting also retrospectively collected data. Data will be collected and entered in a secure dedicated web-based database.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patients With an Implanted S-ICD Who Continue to Exercise Regularly

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

study population

The study population will consist of patients with an implanted S-ICD as their first implanted device, who continue to exercise regularly and actively participate in competitive or recreational sports with a sport-intensity above a predefined level

Sport SICD

Intervention Type DEVICE

Follow up

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sport SICD

Follow up

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient (male or female) is \<60 years of age.
2. Patient has an implanted with a new-generation S-ICD \[Boston Scientific EMBLEM, Generations 2 (model A209), 3 (A219) or newer\].
3. Present device is the first defibrillator implanted.
4. Patient has a functioning LATITUDE™ Home-Monitoring-System at home, knows how to use it and sends weekly reports via the home-monitoring system.
5. Patient actively participates in sport activities above a predefined level of exercise (see below).
6. Patient understands that, at present, there is virtually no data on the safety of sport participation for patients with implanted S-ICD system, particularly regarding potential damage caused by sport activities to the S-ICD system, including the subcutaneous electrode.
7. Patient understands that the level of sport activity, type of sport and frequency of exercise activities are entirely at his/her own discretion and responsibility.
8. Patient understands that The Sport S-ICD Study investigator neither encourage nor discourage performance of any given sport.
9. Patient understands that The Sport S-ICD Study is not liable for- and does assume any responsibility for any damages caused by sport participation to the implanted system or the health of patients participating in the study.
10. Patient is willing to provide informed consent to participate in the SPORT S-ICD Study. Informed consent includes agreement to provide all the following information:

1. Clinical data (age, gender, clinical diagnosis, indication for S-ICD implantation, arrhythmic events since S-ICD implantation, adverse events since S-ICD implantation)
2. Type and level of exercise and sport participation at the time of inclusion and during follow-up.
3. Information concerning endpoint events during follow-up.
4. Direct access to the patients' LATITUDE™ Home-Monitoring-System data, both at the time of inclusion and all weekly reports during the follow-up period, until the study ends or the informed consent is revoked. Access to the personal LATITUDE™ Home-Monitoring-System data is in addition to the access by the primary treating physician and only for purpose of data collection for the study. Consent from the patient AND for the primary treating physician (monitoring the patient's LATITUDE data) are required. Once the study ends, participating patients will be notified that the Study Investigators are no longer monitoring his/her LATITUDE Home-Monitoring-System.

Exclusion Criteria

1. Subjects with an inability to communicate well with the investigators.
2. Subjects who are non-cooperative or unwilling to sign consent form.
3. Evidence suggestive of malfunction of the implanted S-ICD system (like abnormal impedance or detected noise) at the time of screening

Minimum Eligible Age

10 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No